Skoči na glavni sadržaj

Sažetak sa skupa

https://doi.org/10.15836/ccar2024.28

Acute thromboaspiration program in pulmonary embolism – a two-year single center experience

Matija Vrbanić orcid id orcid.org/0000-0002-3229-9436 ; Dubrava University Hospital, Zagreb, Croatia
Zoran Marić orcid id orcid.org/0000-0002-9121-4631 ; Dubrava University Hospital, Zagreb, Croatia
Ljiljana Švađumović orcid id orcid.org/0000-0002-9068-2716 ; Dubrava University Hospital, Zagreb, Croatia
Biljana Šego orcid id orcid.org/0000-0002-0806-1233 ; Dubrava University Hospital, Zagreb, Croatia
Darko Navoj orcid id orcid.org/0000-0001-8899-6524 ; Dubrava University Hospital, Zagreb, Croatia
Vlatka Funduk ; Dubrava University Hospital, Zagreb, Croatia
Kristijana Radić ; Dubrava University Hospital, Zagreb, Croatia
Ivica Benko orcid id orcid.org/0000-0002-1878-0880 ; Dubrava University Hospital, Zagreb, Croatia
Nikola Krajna orcid id orcid.org/0009-0008-7628-6603 ; Dubrava University Hospital, Zagreb, Croatia
Marija Antunović orcid id orcid.org/0009-0009-6583-6910 ; Dubrava University Hospital, Zagreb, Croatia


Puni tekst: engleski pdf 140 Kb

str. 28-28

preuzimanja: 43

citiraj

Preuzmi JATS datoteku


Sažetak

Ključne riječi

pulmonary embolism; thromboaspiration

Hrčak ID:

313435

URI

https://hrcak.srce.hr/313435

Datum izdavanja:

17.1.2024.

Posjeta: 94 *



Acute pulmonary embolism (PE) is a form of venous thromboembolism (VTE) that is common and sometimes fatal. The evaluation of patients with suspected PE should be efficient so that patients can be diagnosed, and therapy administered quickly to reduce the associated morbidity and mortality. The decision to use a thromboaspiration device in the treatment of PE depends on several factors and should be carefully evaluated on a case-by-case basis by a medical team. Thromboaspiration can be an appropriate choice in certain situations, but it may not be suitable for all patients with PE. Thromboaspiration is typically considered for severe cases where the patient is hemodynamically unstable or not responding to standard treatments like anticoagulation therapy. (1,2)

We have been using transcatheter thromboaspiration for acute PE as the method of choice for treatment since March 2022. In that period 26 patients were successfully treated invasively. The medical team will assess the potential benefits of thromboaspiration against the risks associated with the procedure. Risks may include bleeding, infection, vascular damage, or embolization of clot fragments. We will show what we have learned through two years of experience about devices for transcatheter thromboaspiration and why they are increasingly valuable tools in the treatment of severe PE.

LITERATURE

1 

Stout KK, Daniels CJ, Aboulhosn JA, Bozkurt B, Broberg CS, Colman JM, et al. 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2019 April 2;73(12):1494–563. https://doi.org/10.1016/j.jacc.2018.08.1028 PubMed: http://www.ncbi.nlm.nih.gov/pubmed/30121240

2 

Setacci C, Benevento D, de Donato G, Galzerano G, Bracale UM, Setacci F, et al. Acute Deep Vein Thrombosis and Pulmonary Embolism: is the Thromboaspiration Device an Appropriate Choice? Transl Med UniSa. 2020 February 20;21:38–46. PubMed: http://www.ncbi.nlm.nih.gov/pubmed/32123681


This display is generated from NISO JATS XML with jats-html.xsl. The XSLT engine is libxslt.